Cargando…

Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma

High-Grade Serous Ovarian Carcinoma (HGSC) is the most incidental and lethal subtype of epithelial ovarian cancer (EOC) with a high mortality rate of nearly 65%. Recent findings aimed at understanding the pathogenesis of HGSC have attributed its principal source as the Fallopian Tube (FT). To furthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gokulnath, Priyanka, de Cristofaro, Tiziana, Manipur, Ichcha, Di Palma, Tina, Soriano, Amata Amy, Guarracino, Mario Rosario, Zannini, Mariastella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966615/ https://www.ncbi.nlm.nih.gov/pubmed/31842477 http://dx.doi.org/10.3390/cancers11122008

Ejemplares similares

Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma
por: Gokulnath, Priyanka, et al.
Publicado: (2020)

PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3
por: Soriano, Amata Amy, et al.
Publicado: (2019)

Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma
por: de Cristofaro, Tiziana, et al.
Publicado: (2016)

TumorMet: A repository of tumor metabolic networks derived from context-specific Genome-Scale Metabolic Models
por: Granata, Ilaria, et al.
Publicado: (2022)

Publisher Correction: TumorMet: A repository of tumor metabolic networks derived from context-specific Genome-Scale Metabolic Models
por: Granata, Ilaria, et al.
Publicado: (2022)

A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
por: Di Palma, Tina, et al.
Publicado: (2014)

Correction to: Clustering analysis of tumor metabolic networks
por: Manipur, Ichcha, et al.
Publicado: (2020)

Clustering analysis of tumor metabolic networks
por: Manipur, Ichcha, et al.
Publicado: (2020)

Identification of Novel Pax8 Targets in FRTL-5 Thyroid Cells by Gene Silencing and Expression Microarray Analysis
por: Di Palma, Tina, et al.
Publicado: (2011)

PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far
por: Di Palma, Tina, et al.
Publicado: (2022)

Neuropilin-2 Is a Newly Identified Target of PAX8 in Thyroid Cells
por: Lucci, Valeria, et al.
Publicado: (2015)

Pax8 modulates the expression of Wnt4 that is necessary for the maintenance of the epithelial phenotype of thyroid cells
por: Filippone, Maria Grazia, et al.
Publicado: (2014)

Magie et physique amusante
por: Robert-Houdin, Jean-Eugène, 1805-1871
Publicado: (1882)

p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway
por: Abe, Rei J., et al.
Publicado: (2020)

Corrigendum: p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway
por: Abe, Rei J., et al.
Publicado: (2021)

Comparative genomics reveals a functional thyroid-specific element in the far upstream region of the PAX8 gene
por: Nitsch, Roberto, et al.
Publicado: (2010)

Atom Interferometry with MAGIS-100 and AION
por: Mitchell, Jeremiah
Publicado: (2021)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Early anteroposterior regionalisation of human neural crest is shaped by a pro-mesodermal factor
por: Gogolou, Antigoni, et al.
Publicado: (2022)

Magie, Médecine et Possession à Gondar
por: Pankhurst, Richard
Publicado: (1969)

La magie dans le roman africain
por: Garnier, Xavier
Publicado: (1999)

MAGI: Methylation analysis using genome information
por: Baumann, Douglas D, et al.
Publicado: (2014)

MAGI2 Gene Region and Celiac Disease
por: Jauregi-Miguel, Amaia, et al.
Publicado: (2019)

Overexpression of Chromosome 21 miRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome Fetuses
por: Izzo, Antonella, et al.
Publicado: (2017)

Identification of aberrantly expressed long non‐coding RNAs in ovarian high‐grade serous carcinoma cells
por: Nakashima, Kengo, et al.
Publicado: (2020)

MAGI-MS: multiple seed-centric module discovery
por: Chow, Julie C, et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

La magie de l'eau : quand l'eau fait vibrer les contes
Publicado: (2007)

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2022)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

MAGI1 Inhibits the Proliferation, Migration and Invasion of Glioma Cells
por: Li, Zhong-Yan, et al.
Publicado: (2019)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
por: Buttarelli, Marianna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4q07h99r2c4q5g67fv4qje7p3q